Modifying Ligand-Induced and Constitutive Signaling of the Human 5-HT4 Receptor
Open Access
- 19 December 2007
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 2 (12), e1317
- https://doi.org/10.1371/journal.pone.0001317
Abstract
G protein–coupled receptors (GPCRs) signal through a limited number of G-protein pathways and play crucial roles in many biological processes. Studies of their in vivo functions have been hampered by the molecular and functional diversity of GPCRs and the paucity of ligands with specific signaling effects. To better compare the effects of activating different G-protein signaling pathways through ligand-induced or constitutive signaling, we developed a new series of RASSLs (receptors activated solely by synthetic ligands) that activate different G-protein signaling pathways. These RASSLs are based on the human 5-HT4b receptor, a GPCR with high constitutive Gs signaling and strong ligand-induced G-protein activation of the Gs and Gs/q pathways. The first receptor in this series, 5-HT4-D100A or Rs1 (RASSL serotonin 1), is not activated by its endogenous agonist, serotonin, but is selectively activated by the small synthetic molecules GR113808, GR125487, and RO110-0235. All agonists potently induced Gs signaling, but only a few (e.g., zacopride) also induced signaling via the Gq pathway. Zacopride-induced Gq signaling was enhanced by replacing the C-terminus of Rs1 with the C-terminus of the human 5-HT2C receptor. Additional point mutations (D66A and D66N) blocked constitutive Gs signaling and lowered ligand-induced Gq signaling. Replacing the third intracellular loop of Rs1 with that of human 5-HT1A conferred ligand-mediated Gi signaling. This Gi-coupled RASSL, Rs1.3, exhibited no measurable signaling to the Gs or Gq pathway. These findings show that the signaling repertoire of Rs1 can be expanded and controlled by receptor engineering and drug selection.Keywords
This publication has 44 references indexed in Scilit:
- Engineering the Melanocortin-4 Receptor to Control Constitutive and Ligand-Mediated Gs Signaling In VivoPLOS ONE, 2007
- Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligandProceedings of the National Academy of Sciences of the United States of America, 2007
- Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptorsNeuropharmacology, 2007
- Regulation of G proteins by human 5-HT1a receptor TM3/i2 and TM5/i3 loop peptidesNeurochemistry International, 2007
- Molecular Determinants in the Second Intracellular Loop of the 5-Hydroxytryptamine-1A Receptor for G-Protein CouplingMolecular Pharmacology, 2006
- Acquisition, Retention, and Recall of Memory After Injection of RS67333, a 5-HT4 Receptor Agonist, Into the Nucleus Basalis Magnocellularis of the RatLearning & Memory, 2003
- Characterization of Serotonin4 Receptors in Adrenocortical Aldosterone-Producing Adenomas: In Vivo and in Vitro StudiesJournal of Clinical Endocrinology & Metabolism, 2002
- Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the β2Adrenergic ReceptorPublished by Elsevier BV ,2001
- Structural Variants of a Human 5-HT1a Receptor Intracellular Loop 3 PeptidePharmacology, 2000
- A bioactive peptide from the transmembrane 5 - intracellular loop 3 region of the human 5HT1a receptorBiochemistry and Cell Biology, 1998